Hormonersatztherapie
Hormonersatztherapie

Möchten Sie mehr zur Hormonerstaztherapie erfahren?

Möchten Sie eine Hormonersatztherapie starten?
Möchten Sie eine Hormonersatztherapie starten?

Befinden Sie sich in den Wechseljahren? Sie können über Fernarzt Ihre Behandlung starten oder auch mit einem unserer Ärzte per Video oder Telefon sprechen.

Möchten Sie einen Arzt sprechen?
Möchten Sie einen Arzt sprechen?

Dann können Sie online ein Gespräch mit unseren Ärzten vereinbaren und per Telefon oder Video um Rat bitten. Sie können außerdem ein Rezept erhalten.

Quellen
  1. The 2017 hormone therapy position statement of The North American Menopause Society. Menopause (New York, NY). 2017;24(7):728-53.
  2. Santen RJ, Stuenkel CA, Burger HG, Manson JE. Competency in menopause management: whither goest the internist? Journal of women's health (2002). 2014;23(4):281-5.
  3. Sprague BL, Trentham-Dietz A, Cronin KA. A sustained decline in postmenopausal hormone use: results from the National Health and Nutrition Examination Survey, 1999-2010. Obstetrics and gynecology. 2012;120(3):595-603.
  4. Chlebowski RT, Cirillo DJ, Eaton CB, Stefanick ML, Pettinger M, Carbone LD, et al. Estrogen alone and joint symptoms in the Women's Health Initiative randomized trial. Menopause (New York, NY). 2013;20(6):600-8.
  5. Stuenkel CA, Davis SR, Gompel A, Lumsden MA, Murad MH, Pinkerton JV, et al. Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline. The Journal of clinical endocrinology and metabolism. 2015;100(11):3975-4011.
  6. Mashchak CA, Lobo RA, Dozono-Takano R, Eggena P, Nakamura RM, Brenner PF, et al. Comparison of pharmacodynamic properties of various estrogen formulations. American journal of obstetrics and gynecology. 1982;144(5):511-8.
  7. Maclennan AH, Broadbent JL, Lester S, Moore V. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. The Cochrane database of systematic reviews. 2004(4):Cd002978.
  8. Nelson HD. Commonly used types of postmenopausal estrogen for treatment of hot flashes: scientific review. Jama. 2004;291(13):1610-20.
  9. Bergendal A, Kieler H, Sundstrom A, Hirschberg AL, Kocoska-Maras L. Risk of venous thromboembolism associated with local and systemic use of hormone therapy in peri- and postmenopausal women and in relation to type and route of administration. Menopause (New York, NY). 2016;23(6):593-9.
  10. Ettinger B. Vasomotor symptom relief versus unwanted effects: role of estrogen dosage. The American journal of medicine. 2005;118 Suppl 12B:74-8.
  11. Marjoribanks J, Farquhar C, Roberts H, Lethaby A, Lee J. Long-term hormone therapy for perimenopausal and postmenopausal women. The Cochrane database of systematic reviews. 2017;1:Cd004143.
  12. Taylor HS, Manson JE. Update in hormone therapy use in menopause. The Journal of clinical endocrinology and metabolism. 2011;96(2):255-64.
  13. Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation. 2011;123(11):1243-62.
  14. Santen RJ, Stuenkel CA, Davis SR, Pinkerton JV, Gompel A, Lumsden MA. Managing Menopausal Symptoms and Associated Clinical Issues in Breast Cancer Survivors. The Journal of clinical endocrinology and metabolism. 2017;102(10):3647-61.
  15. Crandall CJ, Hovey KM, Andrews CA, Chlebowski RT, Stefanick ML, Lane DS, et al. Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study. Menopause (New York, NY). 2018;25(1):11-20.
  16. Joffe H, Soares CN, Petrillo LF, Viguera AC, Somley BL, Koch JK, et al. Treatment of depression and menopause-related symptoms with the serotonin-norepinephrine reuptake inhibitor duloxetine. The Journal of clinical psychiatry. 2007;68(6):943-50.
  17. Berman RS, Epstein RS, Lydick E. Risk factors associated with women's compliance with estrogen replacement therapy. Journal of women's health. 1997;6(2):219-26.
  18. Grady D, Sawaya GF. Discontinuation of postmenopausal hormone therapy. The American journal of medicine. 2005;118 Suppl 12B:163-5.